BioClinica, Inc., (NASDAQ: BIOC) a leading global provider of clinical
trial services, has signed a three-year, multi-million dollar deal with
Cephalon, Inc. for clinical trial technology and support services. As
part of the Service Agreement, US-based data management staff at
Cephalon will be hired by BioClinica to support clinical efforts of
Cephalon.
“Our long-standing relationship with BioClinica supported our analysis
that they were the best partner to deliver clinical data management
services for us. The agreement was cemented on the shared philosophy
that technology-smart people are key for the optimization of our global
clinical development process”
BioClinica will provide end-to-end clinical data management services to
Cephalon global clinical trial operations. Specific tasks include data
management planning, clinical study set-up for electronic data capture
(EDC), medical coding, adverse event reconciliation, clinical data
management, and training for the clinical sites and investigators. The
deal also expands plans by Cephalon to use BioClinica’s ExpressTM
electronic data capture (EDC) product as the default data capture system
across clinical trial phases, from Phases I through IV. BioClinica will
work with other functional service providers selected as part of
Cephalon’s initiative to optimize operational efficiency. BioClinica
said it will see its role with Cephalon extended from one of a
technology provider to that of a “key services partner”.
Mark Weinstein, President and CEO of BioClinica said: "We will help
Cephalon centralize and streamline its clinical data management
operations through improved process standardization, consistency of
delivery, economies of scale and cost savings. There are other
technology players out there and certainly no shortage of service-based
CROs, but BioClinica is the only organization that successfully blends
those models into a true eClinical suite." The two firms have worked
together since 2003 when Cephalon began using Phoenix Data Systems for
electronic data capture. Phoenix Data Systems is now the core of
BioClinica’s eClinical division.
“Our long-standing relationship with BioClinica supported our analysis
that they were the best partner to deliver clinical data management
services for us. The agreement was cemented on the shared philosophy
that technology-smart people are key for the optimization of our global
clinical development process,” said Dr. Charles Morris, Vice President
of Worldwide Clinical Research at Cephalon.
SOURCE BioClinica, Inc.
BioClinica announces acquisition of Blueprint Clinical to drive RBM strategies for clinical trials